CHARM3D paves the way for the efficient printing of free-standing 3D structures that offer high electrical conductivity, self-healing capabilities and recyclability...
July 26, 2024 News Release BioPorto to Debut FDA Approved ProNephro AKI at Upcoming ADLM 2024 Clinical Lab Expo ADLM...
NEW YORK, July 26, 2024 /PRNewswire/ -- The global business intelligence in the healthcare sector market size is estimated to grow...
CHELMSFORD, Mass., July 26, 2024 /PRNewswire/ -- Brooks Automation, a global leader in innovative design, manufacture and commercialization of robotic...
MCLEAN, Va., July 26, 2024 /PRNewswire/ -- The Association of Organ Procurement Organizations (AOPO) has been recognized with a Power...
VANCOUVER, BC / ACCESSWIRE / July 26, 2024 / Jolt Health Inc. ("JOLT" and or "the Company") (CSE:JOLT)(FSE:G1Q0) announced that...
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the...
Growing consumer awareness of enzyme benefits fuels demand for enzyme-based products in various health and wellness sectors. WILMINGTON, Del., July...
According to the latest medical oxygen concentrators market trends, Asia Pacific held largest share in 2023. Rise in prevalence of...
Net sales of $1.70 billion, decrease of 2.4%; organic decline of 2.0%Net income of $93 million; Adjusted EBITDA of $306...
BILLERICA, MA / ACCESSWIRE / July 26, 2024 / OmniGuide Holdings, Inc. (OGH) is thrilled to announce the successful completion...
Southlake, TX, July 26, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the...
Institutional investors include affiliates of Off the Chain Capital and Discovery Capital ManagementMINNEAPOLIS, July 26, 2024 (GLOBE NEWSWIRE) -- OneMedNet...
$30.3 million financing upfront with up to an additional $92.4 million tied to exercise of warrants, with certain of the...
Patients with EGFR ex19del or EGFR L858R mutations, the most common EGFR mutations in NSCLC, currently face a poor prognosis...
Scienture, Inc., a private branded and specialty pharmaceutical company, entered into a business combination with TRxADE Health Inc., in an all-stock transaction...
If approved, Yuvanci® would become the only single tablet combination for treatment for patients with PAH Johnson & Johnson’s comprehensive...
TEL AVIV, Israel, July 26, 2024 (GLOBE NEWSWIRE) -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab) a clinical stage biotechnology company...
Ipsen receives CHMP positive opinions for Iqirvo® (elafibranor) in Primary Biliary Cholangitis and Kayfanda® (odevixibat) in Alagille Syndrome, two rare...
SOUTH SAN FRANCISCO, Calif., July 25, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics...